import { BlogArticle } from './blogArticles'

export interface StrategicTopicItem {
  id: string
  shortLabel: string
  title: string
  slug: string
  icon: string
  badge?: string
  description: string
  seoKeywords: string[]
}

export const WOMENS_HEALTH_STRATEGIC_TOPICS: StrategicTopicItem[] = [
  {
    id: 'normalization-gap',
    shortLabel: '60% Normalization Gap',
    title: 'The 60% Normalization Gap: How AI Symptom Education Breaks the Silence in Women’s Health',
    slug: 'normalization-gap-ai-symptom-education-womens-health',
    icon: '💬',
    badge: 'AI Impact',
    description: '60% of Indian women normalize severe cramps, heavy bleeding, and prolapse. How Dr. Arya AI enables private, non-judgmental symptom triage.',
    seoKeywords: ['symptom normalization Indian women', 'dysmenorrhea silent suffering', 'AI women symptom checker', 'taboo reproductive health India'],
  },
  {
    id: 'pcos-metabolic-twin',
    shortLabel: 'PCOS + Metabolic Twin Epidemic',
    title: 'PCOS & the Metabolic Twin Epidemic in India: The Insulin Resistance & Fatty Liver Connection',
    slug: 'pcos-metabolic-syndrome-twin-epidemic-india',
    icon: '🩺',
    badge: 'ICMR 2024',
    description: '43.1M women with PCOS face a 91.9% dyslipidemia rate and 1 in 3 NAFLD risk. Why metabolic correction must precede symptom masking.',
    seoKeywords: ['PCOS metabolic syndrome India', 'insulin resistance PCOS women', 'HOMA IR test India', 'PCOS non alcoholic fatty liver'],
  },
  {
    id: 'anemia-diagnostics',
    shortLabel: 'Anemia Diagnostics That Work',
    title: 'Anemia Diagnostics That Actually Work: Why Venous Iron & Ferritin Testing Must Replace Capillary Hemocue',
    slug: 'anemia-diagnostics-that-actually-work-ferritin-india',
    icon: '🩸',
    badge: 'Diagnostic Shift',
    description: 'Why capillary tests overestimate hemoglobin, and how Serum Ferritin uncovers non-anemic iron deficiency in 199.5M women.',
    seoKeywords: ['DABS-I study capillary vs venous anemia', 'serum ferritin test Indian women', 'latent iron deficiency hair loss', 'anemia Mukt Bharat test accuracy'],
  },
  {
    id: 'second-opinion-marketplace',
    shortLabel: 'C-Section & Hysterectomy 2nd Opinion',
    title: 'C-Section & Hysterectomy Second-Opinion Marketplace: Reducing Unnecessary Surgeries in India',
    slug: 'c-section-hysterectomy-second-opinion-marketplace-india',
    icon: '⚖️',
    badge: 'Clinical Governance',
    description: 'With 54.1% private C-sections and a 36-year average hysterectomy age, digital second opinions provide non-surgical alternatives.',
    seoKeywords: ['unnecessary C section rate private hospitals India', 'Robson classification C section audit', 'hysterectomy alternatives heavy bleeding', 'second opinion gynecologist Pune'],
  },
  {
    id: 'menopause-white-space',
    shortLabel: 'Menopause: 140M White Space',
    title: 'Menopause in India: The 140-Million Person Healthcare White Space and the Silent Mid-Life Transition',
    slug: 'menopause-140-million-person-white-space-india',
    icon: '🌸',
    badge: '40+ Care',
    description: 'With an average menopause age of 46.2 years, 140M women spend >30 years in postmenopause with minimal clinical support.',
    seoKeywords: ['menopause age in India 46.2', 'perimenopause hot flashes Indian women', 'DEXA scan osteoporosis women 50', 'hormone replacement therapy India'],
  },
  {
    id: 'cancer-screening-scale',
    shortLabel: 'Cancer Screening at Scale',
    title: 'Cancer Screening at Scale for Indian Women: HPV DNA Co-Testing, Liquid-Based Cytology & Early Detection',
    slug: 'cancer-screening-at-scale-cervical-hpv-dna-breast',
    icon: '🎗️',
    badge: 'Preventive',
    description: '98.1% of Indian women have never been screened for cervical cancer. How 5-year HPV DNA self-sampling changes the paradigm.',
    seoKeywords: ['cervical cancer screening HPV DNA India', 'liquid based cytology Pap smear cost', 'breast self exam guidelines women', 'preventive oncology checkup Pune'],
  },
  {
    id: 'female-provider-network',
    shortLabel: 'Female Provider Access Network',
    title: 'Access Infrastructure in Women’s Health: Overcoming Provider Barriers with India’s Verified Female Doctor Network',
    slug: 'access-infrastructure-female-doctor-provider-network',
    icon: '👩‍⚕️',
    badge: 'Access',
    description: '62% of women cite unavailability of female providers as a major barrier. Meditrust connects women with verified female specialists.',
    seoKeywords: ['female gynecologist near me Pune PCMC', 'women doctor teleconsultation Marathi Hindi', 'healthcare access barriers NFHS-5', 'private OB-GYN consultation online'],
  },
  {
    id: 'financial-product-women',
    shortLabel: 'Financial Protection for Women',
    title: 'Financial Products for Women’s Healthcare: Maternity Inflation, Jan Aushadhi Savings & Out-of-Pocket Shields',
    slug: 'womens-health-financial-protection-maternity-insurance',
    icon: '💳',
    badge: 'Savings',
    description: 'With women’s health claims up 37%, transparent cost estimators and Jan Aushadhi 80% generic savings protect family savings.',
    seoKeywords: ['maternity health insurance waiting period India', 'Jan Aushadhi generic savings pregnancy', 'cost of delivery private hospital Pune', 'women health insurance claims FY26'],
  },
  {
    id: 'mental-health-cycle-link',
    shortLabel: 'Mental Health & Menstrual Cycle Link',
    title: 'The Menstrual Cycle & Mental Health Link: Navigating PMDD, Perinatal Mood Disorders & Postpartum Depression',
    slug: 'mental-health-menstrual-cycle-link-pmdd-postpartum',
    icon: '🧠',
    badge: 'Mind-Body',
    description: 'Connecting hormonal fluctuations with anxiety, Premenstrual Dysphoric Disorder (PMDD), and the 22% postpartum depression prevalence.',
    seoKeywords: ['PMDD vs PMS symptoms India', 'postpartum depression screening EPDS India', 'hormonal anxiety luteal phase', 'mental health women menstrual cycle'],
  },
]

export const STRATEGIC_BLOG_ARTICLES: BlogArticle[] = [
  {
    slug: 'normalization-gap-ai-symptom-education-womens-health',
    title: 'The 60% Normalization Gap: How AI Symptom Education Breaks the Silence in Women’s Health',
    subtitle: '60% of Indian women normalize debilitating cramps and heavy bleeding. How Dr. Arya AI bridges the treatment-seeking barrier.',
    excerpt: 'A meta-analysis of 50 Indian studies reveals 60% of women normalize severe reproductive symptoms as "just part of womanhood." Explore how AI triage empowers women to seek timely medical care.',
    category: 'AI Healthcare',
    readTime: '7 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/report_scanner_hud.jpg',
    tags: ['Normalization Gap', 'Women Health AI', 'Dysmenorrhea', 'Endometriosis', 'Dr Arya AI'],
    featured: true,
    content: {
      intro: 'A landmark systematic review and meta-analysis of 50 studies across India (PROSPERO CRD42024562508) revealed a startling reality: while 41.5% of Indian women suffer from reproductive morbidities, only 54.8% ever seek medical treatment. The primary barrier, cited by 60% of sufferers, is the normalization of symptoms—believing that extreme pain, bleeding through multiple pads an hour, or severe pelvic distress is an inevitable part of being a woman.',
      sections: [
        {
          heading: 'Why Symptoms Get Normalized in Indian Households',
          body: [
            'From early adolescence, young girls are frequently told by elder relatives that menstrual pain, nausea, and irregular cycles are normal biological burdens. This cultural conditioning leads to an average diagnostic delay of 8 to 12 years for chronic conditions like endometriosis.',
            'Furthermore, 47% of women report "no perceived need" for medical consultation, and 27.3% cite embarrassment or communication friction when explaining intimate symptoms to busy outpatient doctors.',
          ],
          highlightBox: {
            title: 'The Cost of Silence',
            text: 'Delayed diagnosis of endometriosis and PCOS often leads to tubal scarring, unmanaged metabolic disease, and infertility requiring expensive third-party interventions.',
            type: 'warning',
          },
        },
        {
          heading: 'How Dr. Arya AI Bridges the Gap in Real-Time',
          body: [
            'Dr. Arya provides a 100% private, non-judgmental environment in Marathi, Hindi, and English where women can describe their symptoms anonymously.',
            'By categorizing menstrual symptoms against international FIGO and Rotterdam standards, Dr. Arya validates that severe dysmenorrhea (missing school/work) is NOT normal, and generates a structured summary of questions for their next gynecologist visit.',
          ],
        },
      ],
      faq: [
        {
          question: 'How do I know if my period pain is abnormal?',
          answer: 'Pain that does not respond to simple OTC analgesics, forces you to stay in bed, causes vomiting, or radiates down your thighs is classified as severe dysmenorrhea and warrants gynecological evaluation.',
        },
      ],
      cta: {
        title: 'Discuss Your Symptoms Privately with Dr. Arya',
        buttonText: 'Start Private WhatsApp Chat',
        link: '/symptom-checker',
      },
    },
  },
  {
    slug: 'pcos-metabolic-syndrome-twin-epidemic-india',
    title: 'PCOS & the Metabolic Twin Epidemic in India: The Insulin Resistance & Fatty Liver Connection',
    subtitle: '43.1M Indian women with PCOS face a 91.9% dyslipidemia rate and 1 in 3 fatty liver risk. Why metabolic health is the true battleground.',
    excerpt: 'The 2024 ICMR study across 18 institutions establishes PCOS as a whole-body metabolic disorder. Discover how insulin resistance drives ovarian androgen production and how to reverse it.',
    category: 'Chronic Health',
    readTime: '8 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/report_scanner_hud.jpg',
    tags: ['PCOS India', 'Metabolic Syndrome', 'Insulin Resistance', 'HOMA-IR', 'Fatty Liver NAFLD'],
    featured: true,
    content: {
      intro: 'Polycystic Ovary Syndrome (PCOS) in India is no longer just a gynecological complaint of irregular periods—it has emerged as the epicentre of a metabolic crisis. The ICMR national study of 9,824 women found that 19.6% of reproductive-age women have PCOS, carrying staggering comorbidity rates: 91.9% dyslipidemia, 43.2% obesity risk, and 1 in 3 with Non-Alcoholic Fatty Liver Disease (NAFLD).',
      sections: [
        {
          heading: 'The Biochemical Engine: Hyperinsulinemia Drives Androgens',
          body: [
            'In Indian women, genetic predisposition combined with ultra-processed foods (which have surged 40-fold in sales since 2006) triggers severe insulin resistance at the receptor level.',
            'When blood insulin spikes, it directly binds to receptors on ovarian theca cells, stimulating them to produce excess testosterone and DHEA-S. This stops the maturation of egg follicles and manifests as cystic acne, facial hair (hirsutism), and delayed cycles.',
          ],
          highlightBox: {
            title: 'Fasting Sugar vs. Fasting Insulin',
            text: 'A normal fasting glucose test does NOT rule out insulin resistance. Always measure Fasting Insulin and calculate the HOMA-IR ratio (ideal < 1.9).',
            type: 'tip',
          },
        },
        {
          heading: 'Evidence-Based Reversal Strategy',
          body: [
            '1. Nutritional Inositol: Myo-Inositol combined with D-Chiro Inositol in a physiological 40:1 ratio restores insulin signaling and improves ovulation in 70% of patients.',
            '2. Low-Glycemic Index Nutrition: Reducing refined carbohydrates (maida, polished white rice) and increasing protein to 1g per kg body weight.',
            '3. Progressive Resistance Training: Muscle contractions stimulate GLUT4 glucose transporters independent of insulin.',
          ],
        },
      ],
      faq: [
        {
          question: 'Can PCOS lead to Type 2 Diabetes?',
          answer: 'Yes. Up to 50% of women with untreated PCOS and severe insulin resistance develop prediabetes or Type 2 diabetes by age 40 if lifestyle interventions are not implemented early.',
        },
      ],
      cta: {
        title: 'Check Your PCOS Risk with Rotterdam Screener',
        buttonText: 'Take PCOS Screener',
        link: '/womens-health#interactive-tools',
      },
    },
  },
  {
    slug: 'anemia-diagnostics-that-actually-work-ferritin-india',
    title: 'Anemia Diagnostics That Actually Work: Why Venous Iron & Ferritin Testing Must Replace Capillary Hemocue',
    subtitle: 'Why finger-prick tests overestimate hemoglobin and how Serum Ferritin uncovers hidden iron deficiency in 199.5M women.',
    excerpt: 'NFHS-5 found 57% of women anemic, but the national DABS-I study is moving to venous sampling due to measurement errors. Learn why Serum Ferritin is the true gold standard.',
    category: 'Lab Tests & Diagnostics',
    readTime: '7 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/report_scanner_hud.jpg',
    tags: ['Anemia India', 'Serum Ferritin', 'Capillary Hemocue', 'DABS-I Study', 'Iron Deficiency'],
    featured: false,
    content: {
      intro: 'Anemia remains India’s most widespread nutritional crisis, affecting 199.5 million women of reproductive age. However, a major diagnostic transformation is currently underway: the national DABS-I study has begun replacing traditional capillary finger-prick HemoCue testing with standardized venous blood draws due to significant overestimation and variation.',
      sections: [
        {
          heading: 'The Trap of Non-Anemic Iron Deficiency',
          body: [
            'Over 3 in 4 Indian women consume inadequate dietary iron. When iron intake falls, the body drains cellular iron stores (Serum Ferritin) first to maintain blood hemoglobin.',
            'A woman can have a completely "normal" hemoglobin of 12.0 g/dL while her ferritin is depleted below 15 ng/mL, causing severe chronic hair loss, cognitive fatigue, and palpitations.',
          ],
        },
        {
          heading: 'Recommended Anemia Diagnostic Protocol',
          body: [
            '• Complete Blood Count (CBC) with RBC Indices (MCV, MCH, RDW).',
            '• Venous Serum Ferritin (Fasting, avoiding iron pills for 48 hrs).',
            '• Total Iron Binding Capacity (TIBC) & Transferrin Saturation.',
          ],
        },
      ],
      faq: [
        {
          question: 'What is a healthy ferritin level for women?',
          answer: 'Optimal ferritin for women is between 50 and 150 ng/mL. Levels below 30 ng/mL indicate latent iron deficiency, while below 15 ng/mL indicates severe depletion.',
        },
      ],
      cta: {
        title: 'Compare Ferritin & Anemia Lab Prices in Pune',
        buttonText: 'View Blood Test Directory',
        link: '/womens-health/blood-tests',
      },
    },
  },
  {
    slug: 'c-section-hysterectomy-second-opinion-marketplace-india',
    title: 'C-Section & Hysterectomy Second-Opinion Marketplace: Reducing Unnecessary Surgeries in India',
    subtitle: 'With private C-section rates at 54.1% and average hysterectomy age at 36, digital second opinions provide critical medical governance.',
    excerpt: 'India performs over 54 lakh C-sections annually, with private facilities reaching 80-90% in extreme states. Discover how evidence-based second opinions protect maternal health.',
    category: 'Hospital Concierge',
    readTime: '8 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/report_scanner_hud.jpg',
    tags: ['C-Section Crisis India', 'Hysterectomy Second Opinion', 'Robson Classification', 'Maternal Health'],
    featured: false,
    content: {
      intro: 'Government health data reveals a profound surgical crisis in Indian women’s healthcare: the national C-section rate climbed to 27.2% in 2024–25 (nearly double WHO’s 10–15% ceiling), with private hospitals averaging 54.1% nationally and over 85–90% in states like West Bengal and J&K. Furthermore, the average age of hysterectomy in India is shockingly low at 36 years, often performed for benign heavy bleeding without any prior trial of medical management.',
      sections: [
        {
          heading: 'Why Unnecessary Surgeries Occur',
          body: [
            'In commercial hospital setups, financial incentives, fear of litigation, and convenient scheduling contribute to elective caesareans and premature surgical removal of the uterus.',
            'The World Health Organization strongly advocates for the Robson 10-Group Classification to audit indications for caesareans.',
          ],
          highlightBox: {
            title: 'Hysterectomy at Age 36: The Hidden Long-Term Toll',
            text: 'Removing the uterus and ovaries before age 45 causes sudden surgical menopause, accelerating osteoporosis by 3-fold and dramatically increasing premature coronary artery disease risk.',
            type: 'warning',
          },
        },
        {
          heading: 'How Second Opinions Empower Families',
          body: [
            'Before agreeing to an elective C-section or non-emergency hysterectomy, getting an independent clinical review of the ultrasound, CT scan, and hemoglobin report ensures all non-surgical alternatives (like LNG-IUS hormonal coils, tranexamic acid, or myomectomy) are evaluated first.',
          ],
        },
      ],
      faq: [
        {
          question: 'Are there medical alternatives to hysterectomy for heavy bleeding?',
          answer: 'Yes. In over 75% of non-cancerous cases, medical therapies such as the levonorgestrel intrauterine system (Mirena), endometrial ablation, or tranexamic acid effectively control heavy bleeding without surgery.',
        },
      ],
      cta: {
        title: 'Discuss Your Surgical Case with Dr. Arya',
        buttonText: 'Ask Dr. Arya AI',
        link: '/symptom-checker',
      },
    },
  },
  {
    slug: 'menopause-140-million-person-white-space-india',
    title: 'Menopause in India: The 140-Million Person Healthcare White Space and the Silent Mid-Life Transition',
    subtitle: 'Indian women reach menopause at an average age of 46.2 years. Why mid-life healthcare must expand beyond reproductive years.',
    excerpt: 'With 140 million women in or past menopause in 2026, 79% feel uncomfortable discussing symptoms. Explore the clinical roadmap for hot flashes, bone loss, and cardiometabolic vitality.',
    category: 'Chronic Health',
    readTime: '8 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/report_scanner_hud.jpg',
    tags: ['Menopause India', 'Perimenopause 40+', 'Indian Menopause Society', 'Bone Density DEXA', 'HRT India'],
    featured: false,
    content: {
      intro: 'The Indian Menopause Society estimates that 140 million Indian women are currently in or past menopause, projected to rise to nearly 130 million actively navigating menopausal transition by 2030. Yet, an Abbott survey found that 79% of Indian women are uncomfortable discussing menopause with family or doctors, and 62% have zero knowledge of medical relief options.',
      sections: [
        {
          heading: 'Earlier Onset: The 46.2-Year Reality',
          body: [
            'Unlike Western women who reach menopause around 51 years, the average age of natural menopause in India is 46.2 years (with perimenopause starting at 44.7 years).',
            'Given an average female life expectancy of ~72 years, Indian women spend more than 30 years in postmenopausal life without estrogen protection.',
          ],
        },
        {
          heading: 'Core Health Dimensions After 40',
          body: [
            '1. Vasomotor Symptoms: 75.3% experience debilitating hot flashes and night sweats disrupting REM sleep.',
            '2. Accelerated Bone Loss: 42.5% of women over 50 develop osteoporosis, requiring annual DEXA scans and calcium/D3 therapy.',
            '3. Cardiometabolic Surge: LDL cholesterol and arterial stiffness increase rapidly post-menopause.',
          ],
        },
      ],
      faq: [
        {
          question: 'What are the first signs of perimenopause?',
          answer: 'Subtle cycle irregularity (cycles shortening to 21–24 days or skipping months), night sweats, sudden sleep disruptions, and mood fluctuations in women aged 40–45.',
        },
      ],
      cta: {
        title: 'Check Blood Tests for Women Above 40',
        buttonText: 'View 40+ Blood Checklist',
        link: '/womens-health/blood-tests/blood-tests-for-women-above-40-menopause-bone-heart',
      },
    },
  },
  {
    slug: 'cancer-screening-at-scale-cervical-hpv-dna-breast',
    title: 'Cancer Screening at Scale for Indian Women: HPV DNA Co-Testing, Liquid-Based Cytology & Early Detection',
    subtitle: '98.1% of Indian women have never been screened for cervical cancer. How 5-year HPV DNA testing transforms preventive oncology.',
    excerpt: 'Breast and cervical cancers account for nearly 40% of all cancer cases in Indian women. Discover why early liquid-based cytology and HPV DNA testing offer 99% curability.',
    category: 'Lab Tests & Diagnostics',
    readTime: '7 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/report_scanner_hud.jpg',
    tags: ['Cervical Cancer Screening', 'HPV DNA Test', 'Pap Smear LBC', 'Breast Cancer Mammography', 'Preventive Oncology'],
    featured: false,
    content: {
      intro: 'National Cancer Registry data shows breast cancer cases rising to 2.4 lakh annually, with breast and cervical cancer comprising nearly 40% of all cancers diagnosed in Indian women. However, NFHS-5 data reveals a catastrophic preventive gap: 99.1% of women aged 30–49 have never undergone clinical breast screening, and 98.1% have never had cervical screening.',
      sections: [
        {
          heading: 'Why Cervical Cancer is 100% Preventable',
          body: [
            'Cervical cancer is almost exclusively caused by persistent infection with high-risk oncogenic strains of Human Papillomavirus (HPV 16 and 18). It takes 10 to 15 years for pre-cancerous cellular dysplasia to become malignant.',
            'High-Risk HPV DNA co-testing with Liquid-Based Cytology (LBC) every 5 years identifies precancerous cellular changes decades before symptoms appear, enabling simple outpatient curative treatment.',
          ],
        },
        {
          heading: 'The 3-Pillar Screening Roadmap',
          body: [
            '• Age 21–29: Pap Smear (LBC) every 3 years.',
            '• Age 30–65: High-Risk HPV DNA Test + Pap Smear every 5 years.',
            '• Age 40+: Annual clinical breast examination and baseline digital mammography.',
          ],
        },
      ],
      faq: [
        {
          question: 'Can HPV vaccine be taken by adult women?',
          answer: 'Yes. The HPV vaccine (Gardasil-9 or Cervavac) is recommended up to age 26 universally, and for women aged 27 to 45 following clinical consultation.',
        },
      ],
      cta: {
        title: 'Learn About HPV DNA & Pap Smear Tests',
        buttonText: 'View Cancer Screening Tests',
        link: '/womens-health/blood-tests',
      },
    },
  },
  {
    slug: 'access-infrastructure-female-doctor-provider-network',
    title: 'Access Infrastructure in Women’s Health: Overcoming Provider Barriers with India’s Verified Female Doctor Network',
    subtitle: '62% of Indian women cite absence of female doctors as a healthcare hurdle. How Meditrust builds seamless clinical access.',
    excerpt: 'NFHS-5 highlights that lack of female healthcare providers is a top obstacle for 62% of women. Explore how verified teleconsultation and doorstep phlebotomy eliminate access friction.',
    category: 'Hospital Concierge',
    readTime: '6 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/report_scanner_hud.jpg',
    tags: ['Female Doctor Network', 'Healthcare Access NFHS-5', 'OB-GYN Pune', 'Telehealth India', 'Home Phlebotomy'],
    featured: false,
    content: {
      intro: 'According to NFHS-5, 84% of women in India perceive at least one major obstacle in accessing healthcare, with the unavailability of female healthcare providers (62%), distance (58%), and transportation (56%) topping facility-level barriers. For millions of women, cultural hesitation in discussing intimate symptoms with male providers prevents timely clinical consultation.',
      sections: [
        {
          heading: 'Building a Dignified, Frictionless Care Pathway',
          body: [
            '1. Private Multilingual AI Triage: Dr. Arya allows women to articulate symptoms in their own mother tongue (Marathi, Hindi, English) before speaking to a doctor.',
            '2. Doorstep 60-Minute Phlebotomy: Eliminating long travel to crowded diagnostic labs by deploying trained female phlebotomists for home blood sample collection across Pune & PCMC.',
            '3. Verified Female OB-GYN Network: Fast-track consultation booking with leading female specialists at top partner hospitals including Ruby Hall Clinic, Cloudnine, Sahyadri, and DY Patil.',
          ],
        },
      ],
      faq: [
        {
          question: 'Are home blood collections safe and hygienic for women?',
          answer: 'Yes. All Meditrust partner phlebotomists follow strict vacutainer barcoding, sterile vacuum needles, and temperature-controlled sample transit.',
        },
      ],
      cta: {
        title: 'Find Verified Female Gynecologists in Pune',
        buttonText: 'Explore Doctor Directory',
        link: '/doctors/gynecologist/pune',
      },
    },
  },
  {
    slug: 'womens-health-financial-protection-maternity-insurance',
    title: 'Financial Products for Women’s Healthcare: Maternity Inflation, Jan Aushadhi Savings & Out-of-Pocket Shields',
    subtitle: 'With women’s health insurance claims up 37%, transparent pricing and 80% generic savings prevent financial toxicity.',
    excerpt: 'Maternity claim outgo increased 25% over two years in India, with Tier-II/III cities driving 60% of claims. Learn how Jan Aushadhi generic equivalents save families thousands.',
    category: 'Generic Medicines',
    readTime: '7 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/medicine_generic_savings.jpg',
    tags: ['Maternity Insurance India', 'Jan Aushadhi Generic Savings', 'Delivery Cost Pune', 'Women Health Claims FY26'],
    featured: false,
    content: {
      intro: 'Between FY25 and FY26, health insurance claims for women jumped by 37% in India, with the 20–40 age group accounting for the largest share. With private hospital delivery costs surging to ₹60,000–₹1,50,000 and routine pregnancy supplements costing thousands per trimester, healthcare expenses place immense pressure on middle-class household budgets.',
      sections: [
        {
          heading: 'Where the Money Goes in Maternal Healthcare',
          body: [
            '• Prenatal Vitamins & Progesterone: Branded micronized progesterone (₹450/strip) vs Jan Aushadhi (₹90/strip) = 80% savings.',
            '• Iron & Calcium Supplements: High-cost branded supplements add ₹1,200/month; Jan Aushadhi Ferrous Ascorbate costs just ₹25/strip.',
            '• Diagnostic Tests: Full antenatal lab packages in commercial private hospitals cost ₹8,000–₹15,000 vs ₹3,500 via Meditrust partner network.',
          ],
        },
      ],
      faq: [
        {
          question: 'Are Jan Aushadhi generic medicines safe during pregnancy?',
          answer: 'Yes. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) medicines are manufactured in WHO-GMP certified facilities and meet identical CDSCO bioequivalence standards as branded drugs.',
        },
      ],
      cta: {
        title: 'Compare Generic Medicine Prices Now',
        buttonText: 'Search Jan Aushadhi Prices',
        link: '/medication-comparison',
      },
    },
  },
  {
    slug: 'mental-health-menstrual-cycle-link-pmdd-postpartum',
    title: 'The Menstrual Cycle & Mental Health Link: Navigating PMDD, Perinatal Mood Disorders & Postpartum Depression',
    subtitle: 'Connecting neurosteroid fluctuations with anxiety, Premenstrual Dysphoric Disorder, and the 22% postpartum depression prevalence.',
    excerpt: 'Over 22% of new mothers in India suffer from postpartum depression, and millions experience severe luteal-phase PMDD. Discover how hormonal tracking unlocks mental health clarity.',
    category: 'Chronic Health',
    readTime: '8 min read',
    date: '24 Aug 2026',
    author: {
      name: 'Dr. Arya, MD (OB-GYN Clinical AI)',
      role: 'Lead Women’s Health Companion',
      avatar: '/dr_arya.jpg',
    },
    image: '/dr_arya.jpg',
    tags: ['PMDD India', 'Postpartum Depression EPDS', 'Hormonal Anxiety Luteal Phase', 'Menstrual Mental Health'],
    featured: false,
    content: {
      intro: 'For decades, the profound neurological impact of ovarian hormones on brain chemistry was dismissed. Today, clinical neuroscience confirms that fluctuations in estrogen and progesterone (and their neurosteroid metabolite allopregnanolone) directly modulate GABA and serotonin receptors in the brain, driving severe mood shifts like PMDD and perinatal depression.',
      sections: [
        {
          heading: 'PMDD vs Normal PMS: Knowing the Difference',
          body: [
            'While PMS causes mild irritability and bloating, Premenstrual Dysphoric Disorder (PMDD) causes incapacitating depression, panic attacks, sudden rage, and rejection-sensitive dysphoria strictly in the 7 to 10 days before menstruation (luteal phase), disappearing within 24–48 hours of period onset.',
          ],
        },
        {
          heading: 'Postpartum Depression (PPD): The 5.5-Million Mother Reality',
          body: [
            'Across India, 22% of mothers develop postpartum depression (reaching 26% in Southern states and 24% in urban centers).',
            'Screening at 6 weeks post-delivery using the Edinburgh Postnatal Depression Scale (EPDS) is essential to ensure new mothers receive compassionate counseling, thyroid checks, and medical support.',
          ],
        },
      ],
      faq: [
        {
          question: 'How is PMDD diagnosed?',
          answer: 'PMDD is diagnosed by charting symptoms prospectively over at least two consecutive menstrual cycles to confirm that psychological symptoms strictly correlate with the post-ovulatory luteal phase.',
        },
      ],
      cta: {
        title: 'Track Cycle Symptoms with Dr. Arya',
        buttonText: 'Chat with Dr. Arya AI',
        link: '/symptom-checker',
      },
    },
  },
]
